biology

Lovotibeglogene autotemcel

Lovotibeglogene autotemcel is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Lovotibeglogene autotemcel rather than just read about it. In short: Lovotibeglogene autotemcel, sold under the brand name Lyfgenia, is a lentiviral gene therapy used for the treatment of sickle cell disease. The most common side effects include stomatitis (mouth sores of the lips, mouth, and throat), low levels of platelets, white blood cells, and red blood cells, and febrile neutropenia (fever and low white blood cell count), consistent with chemotherapy and underlying disease.

Key takeaways

Lovotibeglogene autotemcel belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Lovotibeglogene autotemcel to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Lovotibeglogene autotemcel from memory before moving on to harder problems.

Reference excerpt

Lovotibeglogene autotemcel, sold under the brand name Lyfgenia, is a lentiviral gene therapy used for the treatment of sickle cell disease. The most common side effects include stomatitis (mouth sores of the lips, mouth, and throat), low levels of platelets, white blood cells, and red blood cells, and febrile neutropenia (fever and low white blood cell count), consistent with chemotherapy and underlying disease. The US Food and Drug Administration (FDA) approved lovotibeglogene autotemcel in December 2023.

Medical uses Lovotibeglogene autotemcel is indicated for the treatment of people aged twelve years of age and older with sickle cell disease and a history of vaso-occlusive events. The recipient's blood stem cells are genetically modified to produce HbA (T87Q), a gene-therapy derived hemoglobin A, which is similar to the normal adult hemoglobin produced in persons not affected by sickle cell disease. Red blood cells containing HbA (T87Q) have a lower risk of sickling and occluding blood flow. These modified stem cells are then delivered to the recipient. The gene therapy is made from the recipient's own blood stem cells, which are modified, and are given back as a one-time, single-dose infusion as part of a hematopoietic (blood) stem cell transplant. Prior to treatment, the recipient's own stem cells are collected, and then the recipient must undergo myeloablative conditioning (high-dose chemotherapy), a process that removes cells from the bone marrow so they can be replaced with the modified cells in lovotibeglogene autotemcel.

Side effects The US FDA label contains a black box warning about hematologic malignancy (blood cancer).

History The safety and effectiveness of lovotibeglogene autotemcel is based on the analysis of data from a single-arm, 24-month multicenter study in participants with sickle cell disease and history of Vaso-occlusive episodes (VOEs) between the ages of twelve and fifty years. Effectiveness was evaluated based on complete resolution of VOEs (VOE-CR) between six and eighteen months after infusion with lovotibeglogene autotemcel. Twenty-eight (88%) of 32 participants achieved VOE-CR during this time period. The FDA granted the application for lovotibeglogene autotemcel priority review, orphan drug, fast track, and regenerative medicine advanced therapy designations. The FDA granted approval of Lyfgenia to Bluebird Bio Inc. In March 2025, Cohen Children's Medical Center announced that through the use of this treatment the first person in New York State was cured of sickle cell anemia.

Society and culture

Economics The cost effectiveness threshold of the therapy is estimated to be between US$1.35 million to $2.05 million.

Brand names Lovotibeglogene autotemcel is the international nonproprietary name. Lovotibeglogene autotemcel is sold under the brand name Lyfgenia.

References

Further reading Kanter J, Walters MC, Krishnamurti L, Mapara MY, Kwiatkowski JL, Rifkin-Zenenberg S, et al. (February 2022). "Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease". The New England Journal of Medicine. 386 (7): 617–628. doi:10.1056/NEJMoa2117175. PMID 34898139.

External links "Lovotibeglogene Autotemcel (Code C176855)". NCI Thesaurus. Archived from the original on 10 December 2023.

Worked examples

Example 1 — a first encounter with Lovotibeglogene autotemcel

Start with the simplest possible case. Write down what Lovotibeglogene autotemcel claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Lovotibeglogene autotemcel before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Lovotibeglogene autotemcel ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Lovotibeglogene autotemcel

In research: Lovotibeglogene autotemcel appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Lovotibeglogene autotemcel in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Lovotibeglogene autotemcel is common in secondary-school and first-year university syllabi. It links to neighbouring topics Approved gene therapies, Drugs acting on the blood and blood forming organs, Lentiviruses, so understanding it makes those chapters shorter.
In everyday life: Look for Lovotibeglogene autotemcel outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Lovotibeglogene autotemcel” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Lovotibeglogene autotemcel in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Lovotibeglogene autotemcel means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Lovotibeglogene autotemcel out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Lovotibeglogene autotemcel in simple terms?

Why does Lovotibeglogene autotemcel matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Lovotibeglogene autotemcel?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Lovotibeglogene autotemcel.